Jagdish Umakant Nayak's most recent trade in Clinitech Laboratory Ltd. was a Acquisition of 8,400 Equity Shares done at an average price of Rs. 44 . Disclosure was reported to the exchange on Aug. 20, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Jagdish Umakant Nayak's has made SAST transactions in Clinitech Laboratory Ltd. recently where a Acquisition of 8,400 shares done . Disclosure was reported to the exchange on Aug. 19, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinitech Laboratory | Jagdish Umakant Nayak | Promoter | Acquisition | 18 Sep 2025 | 8,400 | 682,900 (29.92%) | 0.37% | - | 18 Aug 2025 18 Aug 2025 |
SAST (29(2)) | - | Market | |
| Clinitech Laboratory | JAGDISH UMAKANT NAYAK | Promoter & Director | Acquisition | 20 Aug 2025 | 8,400 | 682,900 (29.92%) | 0.37% | 44 | 369,600 | 18 Aug 2025 18 Aug 2025 |
Insider Trading | Equity Shares | Market Purchase |